The intensity dependence of the auditory evoked N1 component as a predictor of response to Citalopram treatment in patients with major depression
- PMID: 15337269
- DOI: 10.1016/j.neulet.2004.06.038
The intensity dependence of the auditory evoked N1 component as a predictor of response to Citalopram treatment in patients with major depression
Abstract
The intensity dependence of the auditory evoked N1 ERP component (IDAP) has been suggested as an indicator of central serotonergic neurotransmission with relevance to pharmacological treatment. We report the results of a study evaluating the IDAP in 16 in-patients fulfilling DSM-IV criteria for major depressive episode in the course of treatment with the SSRI Citalopram. Our data revealed a significant correlation between the intensity slopes of the N1 amplitude prior to Citalopram treatment and treatment response: patients with higher intensity slopes of N1 amplitude showed a significantly stronger decrease of HDRS-Score after Citalopram treatment than patients within the lower intensity slope ranges. Our results indicate an association of N1 amplitude intensity dependence with response to antidepressant treatment with Citalopram.
Similar articles
-
The intensity dependence of auditory evoked ERP components predicts responsiveness to reboxetine treatment in major depression.Pharmacopsychiatry. 2005 May;38(3):139-43. doi: 10.1055/s-2005-864126. Pharmacopsychiatry. 2005. PMID: 15902586
-
Clinical symptoms of major depression are associated with the intensity dependence of auditory event-related potential components.Psychiatry Res. 2009 Sep 30;169(2):139-43. doi: 10.1016/j.psychres.2008.06.009. Epub 2009 Aug 22. Psychiatry Res. 2009. PMID: 19700202
-
The intensity dependence of auditory ERP components in unmedicated patients with major depression and healthy controls. An analysis of group differences.J Affect Disord. 2007 Nov;103(1-3):139-45. doi: 10.1016/j.jad.2007.01.018. Epub 2007 Feb 20. J Affect Disord. 2007. PMID: 17316822
-
[Severe forms of depression: the efficacy of escitalopram].Encephale. 2009 Apr;35(2):152-9. doi: 10.1016/j.encep.2008.09.008. Epub 2009 Mar 31. Encephale. 2009. PMID: 19393384 Review. French.
-
[Escitalopram: a chiral agent for treatment of depression].Med Monatsschr Pharm. 2004 May;27(5):148-51. Med Monatsschr Pharm. 2004. PMID: 15171592 Review. German. No abstract available.
Cited by
-
[Monoaminergic function in major depression. A possibly helpful tool for choosing treatment strategy].Nervenarzt. 2006 Jul;77(7):800-8. doi: 10.1007/s00115-005-2042-2. Nervenarzt. 2006. PMID: 16437254 Review. German.
-
Prediction of long-term treatment response to selective serotonin reuptake inhibitors (SSRIs) using scalp and source loudness dependence of auditory evoked potentials (LDAEP) analysis in patients with major depressive disorder.Int J Mol Sci. 2015 Mar 18;16(3):6251-65. doi: 10.3390/ijms16036251. Int J Mol Sci. 2015. PMID: 25794285 Free PMC article. Clinical Trial.
-
Progress in Elucidating Biomarkers of Antidepressant Pharmacological Treatment Response: A Systematic Review and Meta-analysis of the Last 15 Years.Drugs. 2017 Dec;77(18):1967-1986. doi: 10.1007/s40265-017-0819-9. Drugs. 2017. PMID: 29094313
-
Association between BDNF gene polymorphisms and serotonergic activity using loudness dependence of auditory evoked potentials in healthy subjects.PLoS One. 2013 Apr 9;8(4):e60340. doi: 10.1371/journal.pone.0060340. Print 2013. PLoS One. 2013. PMID: 23593198 Free PMC article.
-
Altered processing of sensory stimuli in patients with migraine.Nat Rev Neurol. 2014 Mar;10(3):144-55. doi: 10.1038/nrneurol.2014.14. Epub 2014 Feb 18. Nat Rev Neurol. 2014. PMID: 24535465 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
